Deals

The latest pharma deals — mergers, acquisitions, licensing agreements, and partnerships shaping the business of drug development worldwide.

pass the torch deal sell buy acquisition
Biotech

Summit sells failed antibiotic to OpenAI-backed startup

Summit has cleared out an asset from its pre-ivonescimab history, offloading an antibiotic to the OpenAI-backed startup Biossil for $500,000 upfront.
Nick Paul Taylor Jul 14, 2026 9:17am
arrow shift new direction rebrand

Spero pivots to I&I via $1.1B deal with Innovent antibody

Jul 14, 2026 6:00am
two arrows pointing different directions

Avere goes public via reverse merger, pays $120M for Hansoh drug

Jul 14, 2026 6:00am
CNS central nervous system nerves brain

Insilico’s partner pens $177M pact for ‘mass market’ CNS target

Jul 13, 2026 5:07am
drawing of magnifying glass on a brain

GSK cuts losses on $700M upfront Alzheimer’s collab with Alector

Jul 9, 2026 7:30am
Deal

Scipher picks up Chemomab’s liver disease drug via merger

Jul 8, 2026 9:26am